AXXELENT Trademark

Trademark Overview


On Friday, March 15, 2019, a trademark application was filed for AXXELENT with the United States Patent and Trademark Office. The USPTO has given the AXXELENT trademark a serial number of 79263331. The federal status of this trademark filing is REGISTERED as of Tuesday, March 17, 2020. The AXXELENT trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medicinal and pharmaceutical preparations for use in the syndromic approach for treating pain, headache, fever, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointensal conditions, respiratory disease, obstetrical/gynecological conditions, cardiovascular disease, skin diseases, allergic reactions, musculo-skeletal and joint diseases, kidney and urological disorders, otolaryngological diseases, eye diseases, neurological system diseases, metabolic and endocrinological diseases, hematological diseases, malignant diseases, protozoal infections and conditions, sexually transmitted infections, HIV and other viral infections, nutritional disorders and poisoning; pharmaceutical preparations, namely, contraceptive preparations

Scientific and medical research and development in the fields of medicines, diagnostic aids and radio-pharmaceuticals for the treatment of pain, headaches, fevers, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory conditions, obstetrical/gynecological conditions and contraception, cardiovascular conditions, skin diseases and allergic reactions, musculo-skeletal and joint conditions, kidney and urological disorders, otolaryngological disearcehs, eye conditions, neurological conditions, metabolic and endorcinological conditions, hematolical conditions, trauma and injuries, malignant disease conditions, malaria, tuberculosis, leprosy, sexually transmitted infections, HIV and other viral infections and conditions, protozoa infections and conditions, poisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research infor...
axxelent

General Information


Serial Number79263331
Word MarkAXXELENT
Filing DateFriday, March 15, 2019
Status700 - REGISTERED
Status DateTuesday, March 17, 2020
Registration Number6010415
Registration DateTuesday, March 17, 2020
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedicinal and pharmaceutical preparations for use in the syndromic approach for treating pain, headache, fever, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointensal conditions, respiratory disease, obstetrical/gynecological conditions, cardiovascular disease, skin diseases, allergic reactions, musculo-skeletal and joint diseases, kidney and urological disorders, otolaryngological diseases, eye diseases, neurological system diseases, metabolic and endocrinological diseases, hematological diseases, malignant diseases, protozoal infections and conditions, sexually transmitted infections, HIV and other viral infections, nutritional disorders and poisoning; pharmaceutical preparations, namely, contraceptive preparations
Goods and ServicesScientific and medical research and development in the fields of medicines, diagnostic aids and radio-pharmaceuticals for the treatment of pain, headaches, fevers, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory conditions, obstetrical/gynecological conditions and contraception, cardiovascular conditions, skin diseases and allergic reactions, musculo-skeletal and joint conditions, kidney and urological disorders, otolaryngological disearcehs, eye conditions, neurological conditions, metabolic and endorcinological conditions, hematolical conditions, trauma and injuries, malignant disease conditions, malaria, tuberculosis, leprosy, sexually transmitted infections, HIV and other viral infections and conditions, protozoa infections and conditions, poisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research information in the field of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 20, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressIN

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressIN

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressIN

Trademark Events


Event DateEvent Description
Thursday, July 18, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, July 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 20, 2019ASSIGNED TO EXAMINER
Wednesday, July 24, 2019APPLICATION FILING RECEIPT MAILED
Saturday, July 27, 2019NON-FINAL ACTION WRITTEN
Sunday, July 28, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 19, 2019REFUSAL PROCESSED BY MPU
Monday, August 19, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 6, 2019REFUSAL PROCESSED BY IB
Tuesday, October 1, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 1, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 28, 2019ASSIGNED TO LIE
Tuesday, October 29, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 29, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 21, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, November 21, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, November 21, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 21, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, November 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, January 4, 2020NOTIFICATION PROCESSED BY IB
Tuesday, March 17, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, June 17, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 28, 2020FINAL DISPOSITION PROCESSED
Wednesday, July 29, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 14, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, September 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, September 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, September 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 17, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, October 16, 2025TEAS SECTION 71 RECEIVED